000			02054 a2200565 4500
005			20250513193316.0
264		0	_c19991118
008			199911s 0 0 eng d
022			_a1042-8194
024	7		_a10.3109/10428199909145708 _2doi
040			_aNLM _beng _cNLM
100	1		_aFleming, D R
245	0	0	_aProtracted results of dose-intensive therapy using cyclophosphamide, carmustine, and continuous infusion etoposide with autologous stem cell support in patients with relapse or refractory Hodgkin's disease: a phase II study from the North American Marrow Transplant Group. _h[electronic resource]
260			_bLeukemia & lymphoma _cSep 1999
300			_a91-8 p. _bdigital
500			_aPublication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aCarmustine _xadministration & dosage
650	0	4	_aCombined Modality Therapy
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aEtoposide _xadministration & dosage
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHodgkin Disease _xtherapy
650	0	4	_aHumans
650	0	4	_aInfusions, Intravenous
650	0	4	_aMiddle Aged
650	0	4	_aNorth America
650	0	4	_aRecurrence
650	0	4	_aTransplantation, Autologous
650	0	4	_aTreatment Outcome
700	1		_aWolff, S N
700	1		_aFay, J W
700	1		_aBrown, R A
700	1		_aLynch, J P
700	1		_aBolwell, B J
700	1		_aStevens, D A
700	1		_aGoodman, S A
700	1		_aGreer, J P
700	1		_aStein, R S
700	1		_aPineiro, L A
700	1		_aCollins, R H
700	1		_aGoldsmith, L J
700	1		_aHerzig, G P
700	1		_aHerzig, R H
773	0		_tLeukemia & lymphoma _gvol. 35 _gno. 1-2 _gp. 91-8
856	4	0	_uhttps://doi.org/10.3109/10428199909145708 _zAvailable from publisher's website
999			_c10469224 _d10469224